DOSTARLIMAB

2493 reported adverse events

Drug classes: Programmed Death Receptor-1 Blocking Antibody [EPC]

These side effects are most commonly reported by patients taking DOSTARLIMAB:

# Side effect Count
0 MALIGNANT NEOPLASM PROGRESSION 254
1 OFF LABEL USE 145
2 FATIGUE 133
3 RASH 114
4 ANAEMIA 98
5 ARTHRALGIA 87
6 DIARRHOEA 87
7 DEATH 84
8 NEUROPATHY PERIPHERAL 82
9 THROMBOCYTOPENIA 80
See all common reactions for DOSTARLIMAB

DOSTARLIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MUCINOUS ENDOMETRIAL CARCINOMA 1 0.5000
1 PERITONECTOMY 3 0.2727
2 CARCINOID TUMOUR OF THE MESENTERY 1 0.2500
3 IMMUNOTOXICITY 23 0.2018
4 ENDOMETRIAL CANCER RECURRENT 16 0.1221
5 ENDOMETRIAL CANCER STAGE IV 4 0.1081
6 SKIN GRAFT DETACHMENT 2 0.0833
7 PERITONEAL NEOPLASM 8 0.0748
8 OMENTECTOMY 3 0.0682
9 POLYRADICULONEUROPATHY 3 0.0577
See all enriched reactions for DOSTARLIMAB